Skip to Main content Skip to Navigation
Journal articles

Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.

Abstract : Metformin (dimethylbiguanide) has been used for more than 30 years as an antihyperglycemic agent in the treatment of diabetes mellitus, but its effect on gluconeogenesis is still controversial. In isolated hepatocytes from fasted rats, a significant inhibition of glucose production from lactate/pyruvate (10:1, mol/mol), fructose, alanine or glutamine, following metformin addition, is observed. Moreover, in hepatocytes perifused with dihydroxyacetone as the gluconeogenic substrate and treated with 0.5 mM metformin, an inhibition of the glucose flux and a simultaneous stimulation of the lactate/pyruvate flux were observed. This enhancement of lactate/pyruvate formation appears to be due to an effect on the pyruvate-kinase enzyme. A direct effect of metformin on pyruvate kinase cannot explain this result, since pyruvate-kinase activity was not affected by metformin at this concentration. In contrast, the addition of metformin caused a significant decrease in the cellular ATP concentration, a known allosteric inhibitor of this enzyme. This could explain the stimulation of pyruvate-kinase activity following metformin addition and thus the inhibition of gluconeogenesis.
Document type :
Journal articles
Complete list of metadata
Contributor : Sarah Hamant Connect in order to contact the contributor
Submitted on : Monday, June 1, 2009 - 2:10:44 PM
Last modification on : Friday, November 6, 2020 - 3:46:56 AM


  • HAL Id : inserm-00390262, version 1
  • PUBMED : 8504825



Doriane Argaud, Hubert Roth, Nicolas Wiernsperger, Xavier M Leverve. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes.. European Journal of Biochemistry, Wiley, 1993, 213 (3), pp.1341-8. ⟨inserm-00390262⟩



Record views